Search for content, post, videos
Advertisement

Elekta and Bristol Myers Squibb enter partnership

Elekta has announced a pilot collaboration with Bristol Myers Squibb to develop a digital solution for patients with melanoma.

“We are thrilled to collaborate with Bristol Myers Squibb to potentially advance the use of digital health interventions, such as in the treatment of melanoma,” says Anish Patankar, SVP & Head of Business Line Software at Elekta. “By providing patients with the tools and support they need, we aim to empower them to actively participate in their treatment journey.”

Kaiku Health

The collaboration leverages Elekta’s digital health interventions platform, Kaiku Health, to facilitate communication between healthcare professionals and their patients on symptom management. By utilizing machine learning algorithms, the platform will enable real-time evaluation of patient-reported data, providing healthcare providers with personalized insights that may improve patients’ care pathway and care experience, states the company.

Advertisement

Read more: Kaiku Health – from startup to acquisition

Through personalized symptom monitoring, healthcare professionals can react early and focus on what matters, while enabling their patients to take a more active role in their treatment. In the past two years, Elekta has also entered partnerships with Roche and Novartis to deploy digital tools to provide real-time symptom management by patients and health care providers.